1. |
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl, 2012, 2(1): 1-138.
|
2. |
Mehta RL, Cerdá J, Burdmann EA, et al. International society of nephrology's 0 by 25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, 2015, 385(9987): 2616-2643.
|
3. |
Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey. Lancet, 2015, 386(12): 1465-1471.
|
4. |
Nie S, Feng Z, Tang L, et al. Risk factor analysis for AKI including laboratory indicators: a nationwide multicenter study of hospitalized patients. Kidney Blood Press Res, 2017, 42(5): 761-773.
|
5. |
Beker BM, Corleto MG, Fieiras C, et al. Novel acute kidney injury biomarkers: their characteristics, utility and concerns. Int Urol Nephrol, 2018, 50(4): 705-713.
|
6. |
Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol, 2015, 10(1): 147-155.
|
7. |
Murray PT, Mehta RL, Shaw A, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative Consensus Conference. Kidney Int, 2014, 85(3): 513-521.
|
8. |
Wierstra BT, Kadri S, Alomar S, et al. The impact of "early" versus "late" initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis. Crit Care, 2016, 20(1): 122.
|
9. |
Wald R, Adhikari NK, Smith OM, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int, 2015, 88(4): 897-904.
|
10. |
Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med, 2016, 375(2): 122-133.
|
11. |
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs. delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA, 2016, 315(20): 2190-2199.
|
12. |
Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: introducing precision renal replacement therapy. Blood Purif, 2016, 42(3): 221-223.
|
13. |
VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med, 2008, 359(1): 7-20.
|
14. |
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med, 2009, 361(17): 1627-1638.
|
15. |
Kellum JA, Ronco C. Dialysis: results of RENAL--what is the optimal CRRT target dose?. Nat Rev Nephrol, 2010, 6(4): 191-192.
|
16. |
孙世仁. CRRT治疗剂量再认识//中华医学会肾脏病学分会 2013 年学术年会, 福州: 中华医学会, 2013: S-74.
|
17. |
冯哲, 陈香美, 聂飒飒. 重视急性肾损伤的临床研究. 中华肾病研究电子杂志, 2016, 5(6): 241-243.
|
18. |
Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med, 2017, 43(6): 730-749.
|